- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00127322
The Early High Risk Period for Patients With Heart Failure
The Early High Risk Period for Patients With Incident Heart Failure: A Population Based Study
Many people with heart failure either die or are admitted to the hospital in the first few months after the condition is diagnosed. The reasons for this are currently unclear- but may be due to worsening heart failure or other medical conditions such as angina, heart attack or sudden electrical problems of the heart. The investigators propose to recruit and follow-up 450 people, with a new diagnosis of heart failure for a minimum of six months in a multi-centre observational study at two hospital sites: The Hillingdon (Uxbridge) and The Conquest (Hastings) hospitals. The total study duration will be two years. People will be recruited after a diagnosis of heart failure is made and the study will assess reasons for death or admission to hospital and the psychological impact of the condition on both patients and their carers. This is an observational study and no change will be made to patients' conventional treatment.
Hypotheses:
- The high mortality and hospitalisation rate in the early period after diagnosis of heart failure is related to progressive pump failure; or
- The high mortality in the early period after the diagnosis of heart failure is related to co-morbid events- principally major coronary events such as myocardial infarction or acute coronary syndrome.
This research should help to identify ways of improving the outlook for people with newly diagnosed heart failure. The analysis of the data generated by this study will be supervised by a statistician. Clinical and demographic data will be described using mean + standard deviation, for continuous variables, and absolute numbers and percentages for categorical variables. Group differences will be examined by t-tests for continuous variables and Chi-square (x2) test for categorical variables. Survival will be reported in terms of Kaplan-Meier curves with differences analysed by Cox proportional hazards.
Study Overview
Status
Conditions
Study Type
Enrollment
Contacts and Locations
Study Locations
-
-
-
Hastings, United Kingdom
- The Conquest Hospital
-
London, United Kingdom, UB8 3NN
- Hillingdon Hospital, Pield Heath Road
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinical diagnosis of heart failure
Exclusion Criteria:
- Under age of 18 years
- Unable to give consent
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Martin R Cowie, MD MRCP MSc, Imperial College London and Royal Brompton NHS Trust
- Principal Investigator: Paresh A Mehta, MBChB MRCP, Imperial College and Royal Brompton Trust
- Principal Investigator: Simon W Dubrey, MD MRCP, The Hillingdon Hospitals NHS Foundation Trust
- Principal Investigator: Hugh F McIntyre, MD FRCP, East Sussex Hospitals NHS Trust
- Principal Investigator: David M Walker, MD FRCP, East Sussex Hospitals NHS Trust
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2003EP005B
- PG/03/097
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.